Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Filings indexed 534 across all filing types
Latest filing 2020-05-29 Major Shareholding Noti…
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
SC 13G/A
Major Shareholding Notification
2020-05-29 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-05-29 English
FORM 4 SUBMISSION
Director's Dealing
2020-05-23 English
FORM 4 SUBMISSION
Director's Dealing
2020-05-18 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 14, 2020, by RAPT Therapeutics, Inc. It announces the issuance of a press release regarding financial results for the quarter ended March 31, 2020. The text explicitly states that the press release is furnished as an exhibit and that the information is not filed for purposes of certain securities laws. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length is 3673 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full financial report itself.
2020-05-14 English
10-Q
Interim / Quarterly Report Q1 2020
2020-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.